Membrane cofactor protein CD46 controls complement activation on cells, is a receptor for several pathogens, and modulates immune responses by affecting CD8؉ T cells. Cells can release CD46 in an intact form on membrane vesicles and in a truncated form by a metalloproteolytic cleavage. The mechanism of shedding and its relationship to cell physiology has remained unclear. We have found using RNA interference analysis that a disintegrin and metalloproteinase (ADAM) 10 is responsible for the regulated shedding of the ectodomain of CD46 in apoptotic cells. The shedding of CD46 was initiated with staurosporine and UVB. Exposure of cell cultures to either UVB or staurosporine resulted in changes of cell morphology and detachment of cells from their matrices within 8 -24 h. During this process CD46 was released both in apoptotic vesicles (vCD46) and proteolytically (sCD46) into the medium. Both the metalloproteinase inhibitor GM6001 and RNA interference of ADAM10 completely prevented the release of sCD46 and increased the expression of vCD46 on HaCaT cell vesicles, suggesting that ADAM10 releases sCD46 from the apoptotic vesicles. To explore whether the release of sCD46 is associated with apoptosis we analyzed the effects of caspase inhibitors. As expected, the inhibition of caspase activity attenuated the characteristic features of apoptosis and also decreased the release of sCD46. Our results reveal ADAM10 as an important regulator of CD46 expression during apoptosis. The ADAM10-mediated release of CD46 from apoptotic vesicles may represent a form of strategy to allow restricted complement activation to deal with modified self.Almost ubiquitously expressed membrane cofactor protein CD46 is a complement regulator that protects cells and tissues from complement damage (1). CD46 can also function as a receptor for several pathogens (2). Cross-linking of CD46 initiates signaling events in a number of cell types (3-6). Recently it was found that CD46 can modulate immune responses by affecting CD8 ϩ T cell cytotoxicity, CD4 ϩ T cell proliferation, and the production of interleukin-2, -10, and transforming growth factor- (7). Furthermore, CD46 induces T-regulatory cell 1 phenotype (8). Normally membrane-bound CD46 has been detected in a soluble form in the cerebrospinal fluids of multiple sclerosis patients with a human herpesvirus 6 infection, for which CD46 has been reported to be a receptor (9). The sera from both normal individuals and cancer patients contain three forms of CD46 with the molecular masses of 56, 47, and 29 kDa. The levels of the 56-and 42-kDa forms are increased in the sera of cancer patients (10). Elevated levels of CD46 have been observed in the sera of patients with systemic lupus erythematosus (11); the urine of patients with glomerular diseases contains three molecular mass forms of CD46 (52, 46, and 35 kDa) (12).Matrix metalloproteinases and the closely related a disintegrin and metalloproteinase (ADAM) 2 family of membranebound proteases have the capacity to convert transmembrane proteins into s...